Results 251 to 260 of about 514,419 (396)

CLINICAL EVALUATION OF PERCUTANEOUS TRANSHEPATIC ENDOPROSTHESIS WITH AN EXPANDABLE METALLIC STENT FOR MALIGNANT BILIARY STENOSIS

, 1994
Toyokazu Furumoto, Satoshi Ohfuji, Takashi Sawata, Yoshihiro Kawamura, Kiyoshi Kishi, Kazuyoshi KATOH   +5 more
openalex   +2 more sources

Severe Vasoplegic Syndrome Treated with Angiotensin II and Hemoadsorption Therapy after Cardiac Surgery

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Vasoplegic syndrome (VS) is a common complication after cardiac surgery with cardiopulmonary bypass (CPB). The main pathophysiology mechanism of VS includes a systemic inflammatory response syndrome due to surgical trauma, release of pro‐inflammatory mediators caused by blood contact with foreign surfaces of heart‐lung machine (pump and tubing)
Matteo Lucchelli, Davide Tommaso Andreis, Mattia Gomarasca, Giovanni Mistraletti   +3 more
wiley   +1 more source

Modulated Degradation of Polylactic Acid Electrospun Coating on WE43 Stents. [PDF]

Polymers (Basel)
Macías-Naranjo M, Antunes-Ricardo M, Moreno González C, De la Peña Aguirre AN, Rodríguez CA, García-López E, Vazquez-Lepe E.   +6 more
europepmc   +1 more source

Expandable Metal Stents for Gastric-Outlet, Duodenal, and Small-Intestinal Obstruction

, 1999
Roy Soetikno, David L. Carr‐Locke
openalex   +1 more source

Nonsurgical Reconstruction of Thoracic Aortic Dissection by Stent–Graft Placement [PDF]

, 1999
Christoph Nienaber, Rossella Fattori, Gunnar Lund, Christoph Dieckmann, Walter Wolf, Yskert Von Kodolitsch, V. Nicolas, Angelo Pierangeli   +7 more
openalex   +1 more source

Outcomes With Intravascular Ultrasound-Guided Stent Implantation: A Meta-Analysis of Randomized Trials in the Era of Drug-Eluting Stents

Circulation. Cardiovascular Interventions, 2016
I. Elgendy, Ahmed N. Mahmoud, Akram Y. Elgendy, A. Bavry   +3 more
semanticscholar   +1 more source

Drug Coated Balloons Versus Drug‐Eluting Stents in Patients With De Novo Coronary Artery Disease

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background In patients with de novo coronary artery disease (CAD), percutaneous coronary intervention (PCI) with drug eluting stent (DES) implantation is the gold standard therapy. New evidence is available with drug coated balloons (DCB) angioplasty. The objective of this meta‐analysis was to compare the efficacy and safety of DCB angioplasty
Daniel O'Callaghan, Himanshu Rai, Daniele Giacoppo, J. J. Coughlan, Rory Durand, Valeria Paradies, Róisín Colleran, Gavin J. Blake, Fernando Alfonso, Robert A. Byrne   +9 more
wiley   +1 more source

Adjunctive stent implantation following directional coronary atherectomy in patients with coronary artery disease

, 1998
Ezio Bramucci, L Angoli, Piera Angelica Merlini, Paolo Barberis, Maria Luisa Laudisa, Elisabetta Colombi, Arnaldo Poli, Jacek Kubica, Diego Ardissino   +8 more
openalex   +1 more source

Four-Year Follow-up of Palmaz-Schatz Stent Revascularization as Treatment for Atherosclerotic Renal Artery Stenosis [PDF]

, 1998
Gerald Dorros, Michael R. Jaff, Lynne Mathiak, Isa I. Dorros, Adam Lowe, Kelly J. Murphy, Thomas He   +6 more
openalex   +1 more source

Navigating Pharmacogenomic Testing in Practice: Who to Test and When to Test

Clinical Pharmacology &Therapeutics, EarlyView.
There is increasing attention on the clinical utility and value of pharmacogenetic (PGx) testing to individualize medication management. Most clinical practice guidelines from medical professional societies do not recommend routine PGx testing, with a few key exceptions.
James M. Stevenson, D. Max Smith, Sony Tuteja, Jai N. Patel, on behalf of the Pharmacogenomics Global Research Network (PGRN) Publications Committee   +4 more
wiley   +1 more source